SCHEMBL29944871

SCHEMBL29944871

CCOC(=O)c1cccc(NC(=O)c2sccc2S(=O)(=O)N(C)c2ccc(Cl)cc2)c1

nearest known ligand 0.79

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SREBF1 P36956 15/20 0.79
NR1H3 Q13133 12/20 0.79
NR1H2 P55055 12/20 0.79
MAPT P10636 2/20 0.55
MAPK1 P28482 2/20 0.55
LMNA P02545 2/20 0.55
NPC1 O15118 1/20 0.55
ALDH1A1 P00352 1/20 0.55
RAB9A P51151 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
TP53 P04637 1/20 0.53
HSD17B10 Q99714 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27245334 1.00 SREBF1 (0.79) SREBF1NR1H3NR1H2MAPTMAPK1
SCHEMBL27030601 0.90 SREBF1 (0.89) SREBF1NR1H3NR1H2MAPTMAPK1
SCHEMBL27245362 0.90 SREBF1 (0.79) SREBF1NR1H3NR1H2MAPTMAPK1
SCHEMBL27245333 0.89 SREBF1 (0.80) SREBF1NR1H3NR1H2MAPTMAPK1
SCHEMBL29944868 0.89 SREBF1 (0.80) SREBF1NR1H3NR1H2MAPTMAPK1
SCHEMBL27030539 0.88 SREBF1 (1.00) SREBF1NR1H3NR1H2MAPTMAPK1
SCHEMBL29944856 0.88 NR1H2 (1.00) SREBF1NR1H3NR1H2MAPTMAPK1
SCHEMBL27030486 0.88 NR1H2 (1.00) SREBF1NR1H3NR1H2MAPTMAPK1
SCHEMBL29944859 0.87 SREBF1 (0.89) SREBF1NR1H3NR1H2MAPTMAPK1
SCHEMBL27245361 0.87 SREBF1 (0.89) SREBF1NR1H3NR1H2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308554-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA The Board of Trustees of the University of Illinois (US) 2024-01-24 EP disclosed
WO-2022197658-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-09-22 WO disclosed